ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Nevro Corp

Nevro Corp (NVRO)

4.31
0.08
( 1.89% )
업데이트: 01:54:06

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
4.31
매수가
-
매도가
-
거래량
95,070
4.20 일간 변동폭 4.40
3.95 52주 범위 22.64
market_cap
전일 종가
4.23
개장가
4.25
최근 거래 시간
1
@
4.32
마지막 거래 시간
01:54:06
재정 규모
US$ 407,318
VWAP
4.2844
평균 볼륨(3m)
552,427
발행 주식
37,471,622
배당수익률
-
주가수익률
-1.78
주당순이익(EPS)
-2.46
매출
425.17M
순이익
-92.21M

Nevro Corp 정보

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Nevro Corp is listed in the Surgical,med Instr,apparatus sector of the 뉴욕 증권거래소 with ticker NVRO. The last closing price for Nevro was US$4.23. Over the last year, Nevro shares have traded in a share price range of US$ 3.95 to US$ 22.64.

Nevro currently has 37,471,622 shares in issue. The market capitalisation of Nevro is US$158.50 million. Nevro has a price to earnings ratio (PE ratio) of -1.78.

NVRO 최신 뉴스

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches PR Newswire REDWOOD CITY, Calif., Nov. 18...

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif., Nov. 15, 2024 REDWOOD CITY, Calif., Nov. 15, 2024 /PRNewswire/ -- Nevro Corp. (NYSE:...

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally PR Newswire REDWOOD CITY, Calif., Nov. 12, 2024 HFX iQ...

Nevro Reports Third-Quarter 2024 Financial Results

Nevro Reports Third-Quarter 2024 Financial Results PR Newswire REDWOOD CITY, Calif., Nov. 11, 2024 Reaffirms Full-Year 2024 Revenue Guidance and Raises Full-Year 2024 Adjusted EBITDA...

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire REDWOOD CITY, Calif., Oct. 29, 2024 Analysis Marks the First...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.12-2.708803611744.434.5853.959436624.27982108CS
4-0.6-12.21995926684.916.853.957744124.90149442CS
12-1.55-26.45051194545.866.853.955524275.16381439CS
26-6.1-58.597502401510.4110.513.956087816.58391644CS
52-12.16-73.831208257416.4722.643.9557410810.87770892CS
156-82.53-95.036849378286.8498.123.9557271032.78683663CS
260-102.54-95.9663079083106.85188.143.9551385966.29523166CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CTVInnovid Corp
US$ 3.025
(86.73%)
43.79M
SNOWSnowflake Inc
US$ 169.50
(31.27%)
33.86M
ODVOsisko Development Corporation
US$ 1.8907
(27.75%)
1.24M
ALURAllurion Technologies Inc
US$ 0.559101
(22.13%)
416.12k
UTIUniversal Technical Institute Inc
US$ 23.89
(20.11%)
638.28k
CATOCato Corp
US$ 5.00
(-17.76%)
125.71k
KLCKindercare Learning Companies Inc
US$ 19.42
(-14.82%)
369.11k
CLCOCool Company LTD
US$ 9.07
(-14.76%)
1.36M
ZIMZIM Integrated Shipping Services Ltd
US$ 23.3838
(-13.43%)
8.87M
DNMRDanimer Scientific Inc
US$ 5.15
(-9.81%)
50k
CTVInnovid Corp
US$ 3.025
(86.73%)
43.79M
SNOWSnowflake Inc
US$ 169.50
(31.27%)
33.86M
PLTRPalantir Technologies Inc
US$ 62.395
(0.44%)
31.04M
NIONIO Inc
US$ 4.6955
(0.98%)
28.28M
IONQIonQ Inc
US$ 30.90
(7.07%)
22.83M

NVRO Discussion

게시물 보기
whytestocks whytestocks 5 년 전
News: $NVRO Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro   (NYSE: NVRO) , a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a...

Find out more NVRO - Here's Why Nevro Stock Bounded Higher on Thursday
👍️0
joseytheoutlawwales joseytheoutlawwales 5 년 전
New system with both lower frequency ranges and combination therapies, in addition to HF10 (10k Hz) ranges, and brand new patient peripherals (ie, remote, charger, etc) should be out in November I’m told.

Should be interesting.
👍️0
whytestocks whytestocks 5 년 전
News: $NVRO Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...

In case you are interested https://marketwirenews.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-8248992.html
👍️0
stocktrademan stocktrademan 6 년 전
NVRO buy 61.44



normal chart







log chart






👍️0
KOmani KOmani 6 년 전
Down 14% on no news at all ....

Perhaps a little overdone?
👍️0
jimmybob jimmybob 8 년 전
$NVRO now up 49.3% YTD,closing at another all-time high today,and hitting all-time highs intra-day.. story not over… http://www.optionmillionaires.com/bull-case-nevro-nvro-update/
👍️0
jimmybob jimmybob 8 년 전
The Bull Case on Nevro ( $NVRO ) - Update : http://www.optionmillionaires.com/bull-case-nevro-nvro-update/ $MEDT $STJ $BSX $NURO $ETRM
👍️0
BudFoxWallStreet BudFoxWallStreet 8 년 전
Nevro's Revenue Surges, Lower Than Expected Loss |

https://www.medtechy.com/the-ticker/articles/2016/nevros-revenue-surges-lower-than-expected-loss

👍️0
jimmybob jimmybob 8 년 전
Snapshot on why I have/continue to love $NVRO (CC still going w/ speechless analysts) - http://www.optionmillionaires.com/bull-case-nevro-nvro/

👍️0
jimmybob jimmybob 9 년 전
One of the best growth stories out there, $NVRO revenue up 114% in ’15 looking for 137%+ in ’16

👍️0
jimmybob jimmybob 9 년 전
$NVRO - strong support around $65 , like for new all-time highs before Q1 earnings in May

👍️0
jimmybob jimmybob 9 년 전
Love the breakout on $NVRO friday.. $70+ next

👍️0
BudFoxWallStreet BudFoxWallStreet 9 년 전
Here is Nevro's JP Morgan presentation. They are also presenting at Leerink tomorrow but it is probably the same presentation.

https://www.medtechy.com/boards/companies/nevro/3825

👍️0
jimmybob jimmybob 9 년 전
Key theme from $NVRO @ #JPM16 : ’Expanding Market opportunities’ outside of $1.5 addressable market where its already taking sizable share
👍️0
RealGenius RealGenius 9 년 전
No way 1 billion MC justified here, when not even profitable.
👍️0
quaerere quaerere 9 년 전
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
👍️0
stocktrademan stocktrademan 9 년 전
$NVRO recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com

[img]http://charts.stockscores.com/chart.asp?

TickerSymbol=NVRO&TimeRange=400&Interval=d&Volume=1&ChartType=CandleStick&ChartWidth=830&ChartHeight=500&LogSc

ale=None&Band=BB&avgType1=EMA&movAvg1=50&indicator1=MACD&candles=redgreen[/img]

big daily chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

big weekly chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVRO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVRO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVRO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/news - http://finance.yahoo.com/q/h?s=NVRO

+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVRO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVRO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVRO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C

+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVRO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?

action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVRO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVRO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVRO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVRO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVRO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVRO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVRO+NVROh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVRO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVRO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVRO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVRO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVRO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVRO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVRO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVRO
Bussinessweek (businessweek.com):

http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVRO
StockTwits (stocktwits.com): http://stocktwits.com/symbol/NVRO

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO
👍️0
uptowndw uptowndw 10 년 전
WTF???? huge jump but on only 2k shares how is this possible?????
👍️0
Penny Roger$ Penny Roger$ 10 년 전
My back hurts. Congrats on IPO $NRVO!

https://www.google.com/finance?q=NVRO

Nevro Corp. is a medical device company focused on developing solutions in the neuromodulation space. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. The Company’s High-frequency spinal cord stimulation (SCS) system, the HF10 SCS, is a spinal cord simulation therapy, which provides electric pulses at a rate of approximately 10,000 Hz for spinal cord stimulation in the treatment of chronic back and leg pain. The electrical pulses are conveyed by small electrodes placed in the epidural space and connected to a battery-powered generator implanted under the skin. The Nevro Senza SCS system is available in Europe and Australia. It is undergoing a pivotal clinical trial, which is intended to collect data to support an application for a Nevro Senza implantable spinal cord stimulation system. The Company’s SENZA-RCT study is intended to evaluate the safety and effectiveness of the Senza SCS system.
👍️0

최근 히스토리

Delayed Upgrade Clock